Compare WGS & ODC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WGS | ODC |
|---|---|---|
| Founded | 2017 | 1941 |
| Country | United States | United States |
| Employees | 1300 | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Miscellaneous manufacturing industries |
| Sector | Technology | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | N/A | 1994 |
| Metric | WGS | ODC |
|---|---|---|
| Price | $56.46 | $92.82 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $120.71 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 99.5K |
| Earning Date | 05-04-2026 | 06-04-2026 |
| Dividend Yield | N/A | ★ 1.13% |
| EPS Growth | N/A | ★ 50.45 |
| EPS | N/A | ★ 1.69 |
| Revenue | N/A | ★ $485,572,000.00 |
| Revenue This Year | $29.98 | N/A |
| Revenue Next Year | $25.92 | N/A |
| P/E Ratio | $1,251.58 | ★ $54.93 |
| Revenue Growth | N/A | ★ 10.97 |
| 52 Week Low | $32.21 | $45.61 |
| 52 Week High | $170.87 | $99.03 |
| Indicator | WGS | ODC |
|---|---|---|
| Relative Strength Index (RSI) | 51.16 | 68.43 |
| Support Level | $32.21 | $70.50 |
| Resistance Level | $73.46 | $99.03 |
| Average True Range (ATR) | 4.21 | 3.82 |
| MACD | 1.05 | 0.82 |
| Stochastic Oscillator | 42.45 | 72.92 |
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.
Oil-Dri Corp of America develops, manufactures, and markets sorbent products made predominantly from clay. Its absorbent offerings, which draw liquid up, include cat litter, floor products, toxin control substances for livestock, and agricultural chemical carriers. The company has two segments based on the different characteristics of two primary customer groups, namely the Retail and Wholesale Products Group, which derives maximum revenue, and the Business-to-Business Products Group. The company's products are sold under various brands such as Cat's Pride, Jonny Cat, Amlan, Agsorb, Verge, Pure-Flo, and Ultra-Clear.